$XYL Income Statement | Understand Stock

$XYL

$108.24 -$0.50 (0.46%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Product
Service
Total revenue
Cost of revenue
Product
Service
Total cost of revenue
Gross profit
Selling, general and administrative expenses
Research and development expenses
Restructuring and asset impairment charges
Goodwill, Impairment Loss
Operating income
Interest expense
U.K. pension settlement expense
Gain on remeasurement of previously held equity interest
Other non-operating income, net
Loss on sale of businesses
Income before taxes
Income tax expense
Net income
Net loss attributable to non-controlling interests
Net income attributable to Xylem
Earnings per share:
Basic (in dollars per share)
Diluted (in dollars per share)
Basic (in shares)
Diluted (in shares)
Dividends declared per share (in usd per share)

Comments